Literatuur antidepressiva gedurende zwangerschap
- Anonymus
Neonatal complications after intrauterine exposure to SSRI antidepressants
Prescrire International (2004) 13, 103-104 - Bar-Oz, B., Einarson, T., Einarson, A., e.a.
Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors
Clinical Therapeutics (2007) 29, 918-926 - Berle JO, Spigset O.
Antidepressant use during breastfeeding
Current Women's Health Reviews 2011;7:28-34 - Gentile S, Rossi A, Bellantuono C.
SSRIs during breastfeeding: spotlight on milk-to-plasma ratio
Arch Womens Ment Health 2007;10:39-51 - Hallberg, P., Odlind, V., & Sjöblom, V.
Selective serotoninreuptake inhibitors and persistent pulmonary hypertension of the newborn
The New England Journal of Medicine (2006) 354, 2188-2190 - Heikkinen T, Ekblad U, Palo P, Laine K
Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
Clin Pharmacol Ther 2003;73:330-7 - Horst PGJ ter, Smit JP
Antidepresiva tijdens de zwangerschap
Nederlands Tijdschrift voor psychiatrie (2009) 5: 307-314 - Huybrechts KF, Palmsten K, Avorn J et all.
Antidepressant use in pregnancy and the risk of cardiac defects.
NEJM 2014;370:2397-2407 - Källén, B.
The safety of antidepressant drugs during pregnancy.
Expert Opinion on Drug Safety (2007) 6, 357-370 - Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, et al.
Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
BMJ. 2012;344(jan12 3):d8012 - Lars Henning Pedersen, Tine Brink Henriksen, Jørn Olsen
Fetal Exposure to Antidepressants and Normal Milestone Development at 6 and 19 Months of Age
Pediatrics March 1, 2010 vol. 125 - National Collaborating Centre for Mental Health (2007)
Antenatal and postnatal mental health.
Clinical Management and Service Guidance. NICE clinical guideline 45 (pp. 1-48)
London: RCOG Press - Misri, S., & Kostaras, X.
Benefits and risks to mother and infant of drug treatment for postnatal depression
Drug Safety (2002) 25, 903-911 - National Collaborating Centre for Mental Health (2007)
Antenatal and postnatal mental health.
Clinical Management and Service Guidance. NICE clinical guideline 45 (pp. 1-48)
London: RCOG Press - Way, C.M.
Safety of newer antidepressants in pregnancy
Pharmacotherapy (2007) 27, 546-552 - Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, Wisner KL
Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants
Am J Psychiatry 2004;161:1066-78 - Grigoriadis S, Mamisashvili L, Ross LE.
Achieving the Balance: Treating Depressed Pregnant Women With Antidepressants.
The Journal of Clinical Psychiatry. 2013,74(4):375-6 - Risselada, AJ
Veranderingen in farmacokinetiek tijdens de zwangerschap
Psyfar 2015 3: 51-57 - Reefhuis et al
Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports
BMJ 2015 - Anderson KN, Lind JN, Simeone RM, et al.
Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
JAMA Psychiatry. 2020;77(12):1246–1255. doi:10.1001/jamapsychiatry.2020.2453
